AnaptysBio Inc. is a clinical-stage biotechnology company that focuses on the development of antibody-based therapies for the treatment of inflammation and immuno-oncology disorders.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!